B. Riley Has Negative Estimate for InfuSystem Q1 Earnings

InfuSystem Holdings, Inc. (NYSE:INFU) – Equities research analysts at B. Riley cut their Q1 2025 earnings per share estimates for InfuSystem in a research report issued to clients and investors on Tuesday, March 4th. B. Riley analyst K. Bauser now expects that the company will post earnings of ($0.03) per share for the quarter, down from their prior forecast of $0.04. The consensus estimate for InfuSystem’s current full-year earnings is $0.15 per share. B. Riley also issued estimates for InfuSystem’s Q4 2025 earnings at $0.12 EPS.

Separately, StockNews.com cut InfuSystem from a “strong-buy” rating to a “buy” rating in a report on Thursday.

InfuSystem Stock Performance

Shares of NYSE:INFU opened at $6.25 on Friday. The stock has a market capitalization of $132.90 million, a P/E ratio of 104.18 and a beta of 1.75. InfuSystem has a 1-year low of $5.74 and a 1-year high of $9.97. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50. The business has a 50-day moving average price of $7.96 and a two-hundred day moving average price of $7.60.

Institutional Trading of InfuSystem

Several institutional investors and hedge funds have recently added to or reduced their stakes in INFU. BNP Paribas Financial Markets grew its position in shares of InfuSystem by 66.4% during the 3rd quarter. BNP Paribas Financial Markets now owns 4,076 shares of the company’s stock worth $27,000 after buying an additional 1,626 shares during the period. Wells Fargo & Company MN grew its position in shares of InfuSystem by 51.7% during the 4th quarter. Wells Fargo & Company MN now owns 9,286 shares of the company’s stock worth $78,000 after buying an additional 3,165 shares during the period. Legato Capital Management LLC acquired a new position in shares of InfuSystem during the 4th quarter worth about $85,000. Summit Global Investments acquired a new position in shares of InfuSystem during the 4th quarter worth about $86,000. Finally, Sei Investments Co. acquired a new position in shares of InfuSystem during the 4th quarter worth about $90,000. 71.13% of the stock is owned by institutional investors.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.